Search

everythinglearnresearchcommunity

for

Search:↓

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

Cis-UCA can form new compounds without enzymes, and sulphide donors reduce its UVB-induced toxicity in skin cells.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Physioxia improves keratinocyte protection against oxidative stress and better mimics real skin conditions.

The compound was successfully made and shows potential for treating prostate cancer.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Yoga helps manage PCOS symptoms and improves overall health.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Minoxidil boosts hair cell growth, while cyclosporin does not.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

A reliable method was developed to measure Minoxidil and Finasteride accurately in medicines.